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Abstract 
Background: Female puberty starts when the pituitary hormone producing follicle-
stimulating hormone (FSH) and luteinizing hormone (LH), which will stimulate the 
ovaries to produce estrogen. Delayed puberty with primary amenorrhea in female is 
the lack of breast development followed by the absence of menses 3 years after the 
initiation of breast development. Sex chromosomes have an important role in 
determining the sex, germ cell differentiation of foetus, and reproductive functions of 
an offspring, thus, sex chromosomal aberrations frequently cause primary amenorrhea 
Case presentation: We report two delayed puberty cases with the chief complain of 
primary amenorrhea. Both cases showed hypoplasia of uterus and ovaries on pelvic 
imaging and hormonal assay showed low of FSH. The first case was gonadal 
dysgenesis with 46,XX karyotype and low level of estrogen and the second case was 
a turner syndrome with 45,X karyotype and normal level of estrogen.  
Conclusion: This study reported delayed puberty with primary amenorrhea cases due 
to different chromosomal aberration pattern which have similar clinical features. 
Therefore, cytogenetic examination is needed for any primary amenorrhea cases in 
order to accomplish the confirmatory diagnosis and make a correct intervention and 
treatment.  
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INTRODUCTION 
 Transition period from childhood to adulthood called 
puberty is a maturational process of reproductive 
endocrine system resulting in the achievement of adult 
height, body proportion, genital organ development, and 
reproductive capacity. It is characterized by acquisition 
of secondary sexual characteristics that is the transition 
of breast, pubic and axillary hair described using 
maturity ratings such as Tanner stages from stage 1 to 
stage 5 and menarche is a late marker of puberty.1 In 
female, puberty was began when the pituitary hormone 
releasing follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH) that energizing the granulosa 
cells of the ovarian follicles and corpora luteum to 
produce estrogen.2  
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 The onset of puberty is characterized by the transition 
from Tanner breast stage B1 to B2, and growth spurt 
starts shortly after breasts begin to develop, called 
thelarche. Menarche, the event of a first menstrual 
period in a female adolescent resulting of a matured 
hypothalamic-pituitary-ovarian (HPO) axis, and it 
usually begin 2-3 years after thelarche.3 Timing of 
puberty is strongly controlled by genetic regulation, 
epidemiological study estimated of 50-80% of variation 
is driven by genetic.1, 4 The advancement of puberty, that 
is, the rate of which an individual will accomplish 
fecundity (reproductive performance), fertility, and 
absolute maturation, was determined by genetic.5 Beside, 
environmental factors also play an important role in 
regulating puberty and pubertal progression includes 
cultural, nutrition, psychological, and endocrine 
disruptor chemicals.3, 6 Several pathological states 
influence the timing of puberty either directly or 
indirectly.3 
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 Delayed puberty (DP) is defined as the absence of 
physical signs of puberty by age of 14 years in boys and 
13 years in girls, affecting 2% of the adolescent 
population and is usually associated with adverse health 
problems such as short stature and reduced bone mineral 
density.7 DP is a common concern for patients, parents, 
family, and peers and a common reason of paediatric and 
obstetric endocrine consultation, it is often a self-limited 
which generally spontaneously reaches completion by 
18 years of age. Self-limited DP is found in two third of 
boys and in nearly half of girls.8 DP which occurs 
constitutionally, called constitutional delay of growth 
and puberty (CDGP), characterized by growth 
retardation in childhood and delayed puberty in 
adolescence is strongly associated with genetic 
component, have a family history of DP.9 There are two 
pathophysiological background of DP 1.e; 
hypergonadotropic hypogonadism and central 
hypogonadotropic hypogonadism. Hypergonadotropic 
hypogonadism affects especially in female and Turner 
syndrome is the most case of this type, while, central 
hypogonadotropic hypogonadism or functional 
hypogonadism is mostly due to a chronic disease and 
nutritional or stressing factors that able to inhibit the 
activation of the hypothalamic–pituitary–gonadal (HPG) 
axis, corresponding to approximately in 20% of DP.8 
The aetiology is unknown in the majority of DP patients 
and identification of causal genetic defects in familial 
delayed puberty is complex. HPG axis is inactive until 
the beginning of puberty, characterized by a gradual 
increase in hypothalamic gonadotropin-releasing 
hormone secretion that will stimulate the secretion of 
FSH and LH.1 
 Disorder of sex development (DSD) is a condition of 
atypical chromosomal, gonadal or sexual characteristics 
resulting of urogenital tract development and varied 
clinical phenotype.10 It mostly impacted on gonadal 
function and by that means the puberty-menarche, thus 
the pubertal development may be absent or incomplete.  
 Primary amenorrhea (PA) is defined as lack of 
menarche or absence of menstruation in females of 
reproductive by age 16 when the development of 
secondary sexual characteristic is evident (breast 
development, pubic hair) or by age 14 when there are no 
secondary sexual characteristics are present.11  PA is one 
of the most common reasons of obstetric-gynaecologic 
consultation in adolescent girls. The primary 
amenorrhea is categorized into functional or anatomic 
defect of hypothalamus, pituitary, uterus or ovaries, and 
genetic defect at chromosomal or molecular level. Sex 
chromosomal aberration is the etiological cause of 
primary amenorrhea in almost 25% of cases.12, 13 When 
pubertal development was delayed, a full physical 
examination is needed to consider broad spectrum of 
differential diagnosis.1 Cytogenetic investigations have 
shown a variety of chromosomal abnormalities as a 
major cause of amenorrhea.14  
 Some girls with delayed puberty may have problems 
with their ovaries, either not developing properly or are 
being damaged. This is referred to as primary ovarian 
insufficiency (POI) due to the lack of LH and FSH. Most 
girls with Turner syndrome are extremely short for their 
age and may have certain distinctive physical features, 
such as cubitus valgus, low posterior hairline, webbed 
neck. Hypogonadotropic hypogonadism affects female 
with hypothalamus and pituitary are functioning 
appropriately but have the gonadal failure.15 Female 
gonadal dysgenesis is defined as absence or insufficient 
development of ovaries present with delayed puberty and 
primary amenorrhea.16 
 This study reported two cases patient with DP and PA 
who had different chromosomal aberrations in order to 
convince the important of chromosomal evaluation to 
confirm the diagnosis/aetiology and to assure an 
appropriate treatment.  
 
CASE REPORT 
 Two serial cases were referred to our hospital with 
delayed pubertal and primary amenorrhea.  
 
Case 1 
 An 18-year-old female (III.7) was referred to our 
hospital for delayed puberty and primary amenorrhea. 
Her pubertal status was Tanner I for breast, axilla and 
pubic hair development. Her growth chart was notable for 
a delayed growth spurt. Her weight and height were 26 
kg 143 cm respectively with her BMI 12.7 kg/m2. The 
mother states that she still had used intra uterine device 
(IUD) until two weeks of pregnancy and she was taking 
an oral medicine for adequate uterine prescribed by 
obstetrician. The mother took oral medication due to 
psoriasis on her early pregnancy and used topical 
corticosteroid during pregnancy, but forgot type of 
corticosteroid treatment she had. The mother also 
reported that she did hair coloring which containing 
organic and mineral chemicals every month during 
pregnancy. She delivered normally at 7 months of 
gestational age and assisted by midwife. Her birth weight 
was 2 kg and birth length 43 cm. The patient taking 
medications for almost 11 months due to tuberculosis at 
6 year of age and never check for recovery after 
treatment. She had no abdominal pain, headache, visual 
disturbances, acne or hirsutism. There was no family 
history with the same condition (Figure 1). She had 
hyperactive behavior during childhood and learning 
difficulties. Pubertal timing of the mother and 
grandmother was normal. There was no consanguinity in 
this family. On physical examination there was a vaginal-
introital opening. Pubertal assessment reveals Tanner 
stage I of Breast development, pubic hair and axillary 
hair. The external genitalia were completely female. 
(Figure 2) 
Table 1. Laboratory evaluations of Case 1 
Hormone  Result Reference range 
FSH (mI/ml) 0.96 Follicular phase : 3.03-8.08  
Mid-cycle peak : 2.55-16.69 
Luteal phase : 1.38-5.47 
Post menopause females without 






<9.00 Follicular phase: 18-147  
Pre-ovulatory peak (DO) 93-575  
Luteal phase 43-214  
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  Ultrasonography examination showed hypoplasia 
uterus and ovaries. Cytogenetic analysis showed a 
female karyotype 46,XX without visible chromosomal 
anomaly. 
 A diagnosis of gonadal dysgenesis was made based 
on clinical, laboratory and ultrasonography findings. 
  
Case 2 
 A 16-year-old female (III.5) was referred to our 
hospital for primary amenorrhea. Her growth chart was 
notable for a delayed growth spurt. Her weight was 36 
kg, height 135 cm (-2SD) and her BMI 19.6 kg/m2. She 
had no abdominal pain, headache, visual disturbances, 
acne or hirsutism. There was no family history with the 
same condition (Figure 3). She was born full term and 
delivered normally by midwife. Her birth weight was 3.9 
Kg, and her birth length was 52 cm. 
 Physical examination showed normal female 
external genitalia with introitus vagina. Her pubertal 
status was Tanner I for breast, pubic and axillary hair 
development. There was low posterior hairline, cubitus 
valgus and asymptomatic bilateral short fourth 
metatarsals (brachymetatarsia) (Figure 4). 
 Ultrasonography of abdomen showed hypoplasia 






Figure 1. Pedigree of case 1: affected patients is presented by black filled circle with the arrow (III.7). Healthy members are 
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Figure 2. Physical examination: A. External genitalia is 
completely female with a vaginal-introital opening; B: 
Breast development is Tanner stage I 
 
Table 2. Laboratory evaluations of Case 2 
 Result References range 
FSH 4.88 Follicular phase : 3.03-8.08  
Mid-cycle peak : 2.55-16.69 
Luteal phase : 1.38-5.47 
Post menopause females without 
HRT : 26.72-133.41 
Estradiol 56.03 Follicular phase: 18-147  
Pre-ovulatory peak (DO) 93-575  




Figure 3. Pedigree of case 2. Affected patient is presented by 
black filled circle with the arrow (III.5). Healthy members are 



















Figure 4. Physical examination A. Cubitus Valgus, B. 
External genitalia is completely female with a vaginal-
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 A diagnosis of Turner Syndrome was made based on 
cytogenetic findings combined with the clinical, 
laboratory, and ultrasonography results. 
 
DISCUSSION 
 Many conditions can lead to delayed puberty with 
primary amenorrhea. Puberty is considered delayed 
when there are no signs of breast development by 13 
years of age in female and primary amenorrhea at 15 
years of age.17 The most common etiology of primary 
amenorrhea are the presence of gonadal dysgenesis in 
40% of cases.18 According to previous studies, primary 
amenorrhea due to chromosomal abnormalities was 
reported varied from 15.9% to 63.3% and turner 
syndrome either 45,X or its mosaic form is the leading 
cause of primary amenorrhea.11 A comprehensive family 
history and physical examination and laboratory testing 
of affected individuals are required for diagnosis. The 
clinicians should inquire about the height, weight and 
body mass index of those with delayed puberty since 
they may present with short stature.19  
 Both of cases had the same symptoms of delayed 
puberty (Tanner 1 for breast, pubic hair and axillary hair) 
with primary amenorrhea. Evaluation of delayed puberty 
with primary amenorrhea begins with a complete family 
history and physical examination including the 
assessment of the external genitalia and internal female 
genitalia by ultrasonography as well as determination of 
hormonal status. This approach will identify the most 
common cause of delayed puberty with primary 
amenorrhea.18 Medical history with height and weight 
charts, nutritional status, medications, history and 
symptoms of chronic diseases also needed to evaluate if 
pubertal development is delayed.1 The height can be 
affected by delayed puberty and it is slightly below the 
genetic target.3   
 Increasing estrogen level in girls resulting in gradual 
breast tissue, and pubertal growth spurth.1 The two cases 
had different hormonal results, although both of our cases 
showed hypoplasia of uterus and ovaries on the 
ultrasonography. The first case showed low FSH and 
estrogen levels, while in the second case showed low 
FSH but normal estrogen level.  
 Primary ovarian insufficiency (POI) is a condition 
characterized by follicle depletion or dysfunction leading 
to impaired ovarian function which suggested by low 
level of FSH.20 Both of cases had low level of FSH and 
this is confirmed a POI. Congenital POI can be due to 
gonadal dysgenesis and turner syndrome or variant.20 The 
first case is diagnosed as gonadal dysgenesis due to 
absence or insufficient development of ovaries that 
present with delayed puberty and primary amenorrhea. 
Heterogeneity of genetic defects resulting in delayed 
puberty. The importance of defects in GnRH neuronal 
development and LH/FSH abnormalities due to gene 
mutations also control of pubertal timing. PROP1 
mutations are the most common cause of pituitary 
hormone deficiency in humans that associated with 
delayed puberty.7   
 Morphogenesis and differentiations of Mullerian duct 
(MD) that plays an important role in female reproduction 
can also be impaired due to the effects of teratogens or 
genetic mutation. Defects of MD development can lead 
to disorders of female reproductive tract such as a 
dysplastic or absent vagina, cervix and uterus. Mutation 
has been linked in early MD genes such as L1M1, 
WNT4, and WNT9B can cause MRKH or related 
abnormalities.21 The first case of delayed puberty with 
primary amenorrhea was reported had family history of 
toxic agent and medications which was used during fetal 
development. Furthermore, she had a history of 
tuberculosis during childhood which can be linked to 
chronic disease. Her weight and height were 26 kg 143 
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cm and her BMI showed malnutrition with 12.7 kg/m2. 
Malnutrition has been linked with delayed puberty while 
direct mechanism had not been established.22 The 
karyotype result was 46,XX and this confirmed a 
gonadal dysgenesis. Measurement of FSH, LH and 
estradiol will provide sufficient information to rule out 
organic causes of amenorrhea.1 There was no sex 
chromosomal aberrations were detected. Cytogenetic 
analysis showed 46,XX of the first case, it may be caused 
by mutation in genes that involved in gonadal 
development and differentiation.  
 Turner syndrome is caused by partial or complete 
absence of the X chromosome in female, with 
phenotypic features among affected individuals are 
varied.23 Common physical characteristics in Turner 
syndrome include; short stature, webbed neck, low 
posterior hair line, shield chest or nipple distance, and 
cubitus valgus.24 The second case did not have webbed 
neck, shield chest or nipple distance, and others Tuner 
syndrome stigmata. Physical examination of the second 
case were dysmorphic features such as cubitus valgus, 
low posterior hair lines and brachymetatarsia. The 
observations of this patient indicated a chromosomal 
aberration and therefore, a karyotype was obtained and 
the karyotype result was 45,X confirmed Turner 
syndrome. In recent study, the classical karyotype of 
45,X was only found in 45% of patients. The phenotypic 
of short stature is common in all patients with Turner 
syndrome.25  In this case, her weight was 36 kg and she 
had short stature (-2SD), which is a classical findings of 
Turner syndrome. Brachymetatarsia is a rare condition 
that arises from premature closure of the metatarsal 
epiphyseal plate, while the most common skeletal 
abnormality in turner syndrome is cubitus valgus, that is, 
the premature closure of the antebrachial long bones.26 
The fourth metatarsal is the most frequently involved, 
females are almost exclusively affected, and it can be 
associated with Turner syndrome.27 There are many 
health conditions associated with Turner syndrome, one 
of those is a congenital heart defect in almost 50% of 
cases28, 29 and the mortality rate is increasing three times 
higher among patients with Turner syndrome who have 
congenital heart defect.28 It is important that diagnosis 
and treatment are important to undertake in early life 
Assessment to confirm the type of congenital heart 
disease can be done using echocardiography to 
performed better management and treatment.30 
 
CONCLUSION 
 These cases highlight that cytogenetics can lead to an 
accurate diagnosis of etiology and management of 
delayed puberty with primary amenorrhea cases. Health 
care professionals should be aware that the sexual 
genotype of delayed puberty and primary amenorrhea 
cases to offer appropriate treatment.  
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